Hierarchical Silica Composite for Ethane Dehydrogenation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional dehydrogenation catalysts face issues with stability, toxicity, and inefficiency in oxidative dehydrogenation of ethane to ethylene, and nanosilica carriers for drug delivery suffer from low drug targeting efficiency and limited imaging capabilities.

Innovation Solution

A hierarchical silica composite loaded with an antitumor agent and imaging agents, combined with a catalytic system using nickel and cation dopants, provides a nanotherapeutic with dual imaging capabilities and enhanced catalytic activity for oxidative dehydrogenation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional dehydrogenation catalysts are used, then robustness and activity are achieved, but stability deteriorates due to potassium migration and toxic chromium presence

Engineering Contradiction:
Improvecatalytic activityVSAvoidcatalyst stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention removes harmful components (potassium promoter and toxic chromium oxide) from conventional dehydrogenation catalysts while maintaining catalytic activity through alternative catalyst designs using nickel-based systems with controlled oxidation states and hierarchical porous supports

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention employs composite catalyst systems combining nickel oxide with hierarchical silica composites (integrating microporous zeolite structures with mesoporous materials) to achieve both high activity and enhanced stability without requiring potassium promoters or toxic chromium components

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If nanosilica carriers are used for drug delivery, then delivery capability is provided, but drug targeting efficiency remains low and imaging capabilities are limited

Engineering Contradiction:
Improvedrug delivery capabilityVSAvoiddrug targeting efficiency
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The invention creates multifunctional nanosilica carriers that simultaneously provide drug delivery, magnetic resonance imaging (through incorporated magnetic nanoparticles), and fluorescence imaging (through surface-functionalized fluorophores), while enabling active targeting through ligand conjugation for enhanced tumor specificity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention applies different functional properties to different regions of the nanocarrier system: magnetic nanoparticles are incorporated in specific zones for imaging, targeting ligands are conjugated to surface regions for directional guidance, and drug loading zones are optimized within the porous structure for controlled release

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nanotherapeutic achieves sustained drug delivery and improved imaging sensitivity, while the catalytic system enhances ethane oxidative dehydrogenation efficiency with controlled product distribution and stability.

Implementation Method 1

Structured silica/metal oxide mesosilicates have gained prominent uses in different domains, such as catalysis, drug delivery, and gas adsorption

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

at least one imaging agent selected from the group consisting of a fluorophore and a magnetic resonance imaging moiety

Methodology Applied
Scientific EffectMagnetic resonance imaging: Magnetic Hysteresis

Implementation Method 3

at least one imaging agent selected from the group consisting of a fluorophore and a magnetic resonance imaging moiety

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 4

a catalytic system using nickel and cation dopants, provides a nanotherapeutic with dual imaging capabilities and enhanced catalytic activity for oxidative dehydrogenation

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 5

Oxidative dehydrogenation has significant advantages over conventional dehydrogenation as the process is not limited by thermodynamic equilibrium, can be carried out at lower temperatures

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20230381345A1Method for oxidatively dehydrogenating alkanes
Publication Date: 2023.11.30 IMAM ABDULRAHMAN BIN FAISAL UNIV
  • US20230381345A1 patent drawing
  • US20230381345A1 patent drawing
  • US20230381345A1 patent drawing

AI summary

A nanotherapeutic supported by a hierarchical silica composite with dual imaging capability (e.g. fluorescence and magnetic resonance imaging), a method of preparing the nanotherapeutic, and a method of treating cancer. Also disclosed is a method of oxidatively dehydrogenating ethane using a catalytic system supported by a hierarchical silica composite.